The 2021/22 National Tariff Payment System came into effect in England

12

Oct 2021

On September 30, 2021, the 2020/21 National Tariff Payment System (NTPS) was published in England and came into effect on October 01, 2021. The NTPS is used by commissioners and providers of secondary healthcare. It sets the rules and prices that commissioners use to pay providers (such as acute hospital trusts) for NHS services.

2021/22 NTPS introduced the new aligned payment and incentive model for all secondary care and removed almost all national prices. The most published prices are now "unit prices", which are not mandatory, and National prices continue to apply to diagnostic imaging services only.

Some key changes in the new payment model are outlined below:

  • The aligned payment and incentive approach became the central part of the National Tariff. It is a combination of fixed (global budget) and variable (activity/quality-based) funding;
  • The role of HRG is now limited to cases when the new model does not apply (e.g., providers outside the regular responsibilities of CCGs with the amount of contract less than £10 million) and for a flexible component of the novel system (e.g., for excess care, which will be paid using 50% of national HRG tariff);
  • From 2021/22, there are no separate innovation payment options.
  • The innovative products list (Annex A, tab 14c) includes technologies supported by MedTech Funding Mandate. These products have to be implemented by commissioners and reimbursed under local pricing arrangements;
  • There have been no principal policy changes for the Best Practice Tariff (BPT). The day case and outpatient procedures BPTs were discontinued.

In addition, as part of the response to Covid-19, the NHS has adopted special payment arrangements for 2021/22. Under these arrangements, most providers and commissioners have moved to block contract payments "on-account." The guidance on payment and contracting for these arrangements is available here.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

18

Oct 2021

The NHS Digital extended the application period for changes in the OPCS-4 nomenclature of procedure codes, which is updated every three years. The new deadline for change requests is December 01, 2021. The changes shall be implemented in the OPCS-4.10 version from April 01, 2023.

Read more

15

Oct 2021

The Scottish Health Technologies Group (SHTG) is a national health technology assessment (HTA) agency providing advice to NHSScotland on the use of new and existing health technologies, likely to have a significant impact on healthcare. In the third quarter of 2021, SHTG published only one report in relation to HeartFlow fractional flow reserve computerized tomography (FFRCT). Currently, the SHTG is working on assessments of technologies in the field of diabetes, digital health, surgical procedures, and other topics.

Read more

13

Oct 2021

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in September 2021. In total, 58 recommendations for registration, modification of registration conditions, and removal of devices from the List of reimbursable products and services (LPPR) were published. Opinions concern cardiovascular, orthopedic, peripheral vascular, and other groups of devices, as well as medical aids.

Read more

08

Oct 2021

In September 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis, transapical transcatheter mitral valve-in-ring (TMVIR) after failed annuloplasty for mitral valve repair, and lateral elbow resurfacing for arthritis), and two new Medtech Innovation Briefings (Carnation Ambulatory Monitor, OrganOx metra for liver transplant). Also, one clinical guideline was updated.

Read more

07

Oct 2021

On September 10, 2021, it was announced that the Government of Spain had increased the budget allocated to the Spanish Network of Agencies for the Evaluation of Health Technologies and Benefits (RedETS) by 48.2% (compared to last year) for the development of the annual work plan. In total, the 2021 budget for the evaluation of health technologies in the National Health System amounts to €6,149,510. As a consequence of the budget increase, the RedETS 2021 Work Plan has included three new lines of evaluation.

Read more